0
Article Tier 2 Human Health Effects Policy & Risk Sign in to save

Risk Assessment of Phthalates and Their Metabolites in Hospitalized Patients: A Focus on Di- and Mono-(2-ethylhexyl) Phthalates Exposure from Intravenous Plastic Bags

Toxics 2022 21 citations

AI summary Read the abstract

Researchers measured phthalate exposure from intravenous plastic bags in hospitalized patients in Lebanon, finding elevated levels of DEHP and its metabolite MEHP in blood and urine, raising concerns about medical device-related plasticizer exposure.

Body Systems
Models

Phthalate esters (PAEs) are plasticizers associated with multiple toxicities; however, no strict regulations have been implemented to restrict their use in medical applications in Lebanon. Our study aimed at assessing the potential risks correlated with phthalate exposure from IV bags manufactured in Lebanon. GC-MS analysis showed that di-(2-ethylhexyl) phthalate (DEHP) is the predominant phthalate found in almost all samples tested with values ranging from 32.8 to 39.7% w/w of plastic. DEHP concentrations in the IV solutions reached up to 148 µg/L, as measured by SPME-GC-MS/MS, thus resulting in hazard quotients greater than 1, specifically in neonates. The toxicity of DEHP is mainly attributed to its metabolites, most importantly mono-(2-ethylhexyl) phthalate (MEHP). The IV bag solution with the highest content in DEHP was therefore used to extrapolate the amounts of urinary MEHP. The highest concentrations were found in neonates having the lowest body weight, which is concerning, knowing the adverse effects of MEHP in infants. Our study suggests that the use of IV bags manufactured in Lebanon could pose a significant risk in hospitalized patients, especially infants in neonatal care. Therefore, Lebanon, as well as other countries, should start imposing laws that restrict the use of phthalates in medical IV bags and substitute them with less toxic plasticizers.

More Papers Like This

Article Tier 2

Unraveling micro/nanoplastics and phthalates in infusion solutions: A novel integrated approach for quantification and cardiovascular cytotoxicity evaluation

AI summary Read the abstract

Researchers developed a new method to detect and measure micro- and nanoplastics in medical infusion solutions (IV bags) and found significant contamination in commonly used glucose and saline fluids. Nanoplastics dominated the contamination, with polyethylene, polypropylene, and polystyrene detected alongside phthalate chemicals that showed a strong correlation with plastic particle levels. The study suggests that IV therapy may be an overlooked route of direct plastic particle exposure into the bloodstream, and that combined exposure to nanoplastics and phthalates can have synergistic toxic effects on cardiovascular cells.

Systematic Review Tier 1

Plastic particles in medicine: A systematic review of exposure and effects to human health

AI summary Read the abstract

Medical plastics including bags, containers, and administration sets release micro- and nanoplastics along with chemical additives that can interact with pharmaceutical constituents, creating an understudied route of direct human exposure. Both primary exposure (during medical treatment) and secondary environmental exposure (from hospital plastic waste disposal) represent potential health hazards.

Article Tier 2

Personal Protective Equipment as a Potential Source of Phthalate Exposure during the COVID-19 Pandemic

AI summary Read the abstract

Researchers detected six phthalate plasticizers in various types of personal protective equipment (face masks, face shields, and gloves) collected during the COVID-19 pandemic using GC-MS analysis. PPE made primarily from plastics represents a significant but underappreciated source of phthalate exposure during prolonged wear, particularly in healthcare settings.

Article Tier 2

Hidden hazards: microplastics in intravenous admixtures and their path into the body

AI summary Read the abstract

This study investigated microplastic contamination in intravenous (IV) fluid bags used in hospitals, finding that prolonged storage in plastic containers leads to microplastic particles leaching into the solution. This means patients receiving IV treatments may be exposed to microplastics that enter the bloodstream directly, bypassing the body's natural barriers. The findings highlight an overlooked route of microplastic exposure in medical settings that needs further investigation.

Article Tier 2

Microplastic entry into bloodstream via hemodialysis: A dual-simulation clinical study

AI summary Read the abstract

Researchers measured microplastics in the blood of nine patients before and after hemodialysis, finding that particle counts nearly doubled post-procedure, with polymer types matching dialysis tubing materials — suggesting medical plastic devices are a direct route of microplastic entry into the bloodstream.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper